Mitochondrial membrane protein associated neurodegenration: A novel variant of neurodegeneration with brain iron accumulation

Movement Disorders

Volumn 28, Issue 2, 2013, Pages 224-227

  Schulte, Eva C ^a,b   Claussen, Malte C ^a   Jochim, Angela ^a   Haack, Tobias ^a,b   Hartig, Monika ^a,b   Hempel, Maja ^a,b   Prokisch, Holger ^a,b   Haun Jünger, Ursula ^c   Winkelmann, Juliane ^a,b   Hemmer, Bernhard ^a   Förschler, Annette ^a   Ilg, Rüdiger ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c KLINIKUM BREMEN MITTE   (Germany)

Author keywords

C19orf12; Genetics; Mitochondrial membrane protein associated neurodegeneration (MPAN); MRI; Neurodegeneration with brain iron accumulation (NBIA)

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE;

ACUTE MOTOR AXONAL NEUROPATHY; ARTICLE; CASE REPORT; CHILD; COGNITIVE DEFECT; CREATINE KINASE BLOOD LEVEL; DYSARTHRIA; EYE MOVEMENT; FEMALE; GENERALIZED DYSTONIA; HUMAN; IMPULSIVENESS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE PROTEIN ASSOCIATED NEURODEGENERATION; MUTATION; NERVE DEGENERATION; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; OROMANDIBULAR DYSTONIA; PARKINSONISM; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SPASTICITY;

ADOLESCENT; ADULT; AGE OF ONSET; ATROPHY; BRAIN; BRAIN CHEMISTRY; CHILD; FEMALE; GAIT DISORDERS, NEUROLOGIC; GLOBUS PALLIDUS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MOTOR NEURON DISEASE; MOVEMENT DISORDERS; NEURODEGENERATIVE DISEASES; OPTIC NERVE DISEASES; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PEDIGREE; PHENOTYPE; SUBSTANTIA NIGRA; YOUNG ADULT;

EID: 84874206340     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25256     Document Type: Article

References (13)

1. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33-40.
2. Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet 2009;46:73-80.
3. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.
4. Hartig MB, Hortnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006;59:248-256.
5. Schneider S A, Hardy J, Bhatia K P. Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord 2012;27:42-53.
6. Kruer MC, Boddaert N, Schneider SA, et al. Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol 2012;33:407-414.
7. Hartig MB, Iuso A, Haack T, et al. Absence of an orphan mitochondrial protein (C19orf12) causes a distinct clinical subtype of neurodegeneration with brain iron accumulation (NBIA). Am J Hum Genet 2011;89:543-550.
8. Horvath R, Holinski-Feder E, Neeve VCM, et al. A new phenotype of brain iron accumulation with dystonie, optic atrophy, and peripheral neuropathy. Mov Disord 2012;27:789-793.
9. Morgan NV, Westaway SK, Morton JE, et al. PLA2G6, encoding a phospholipase, A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 2006;38:752-754.
10. Ginat DT, Meyers SP. Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis. Radiographics 2012;32:499-516.
11. Timmermann L, Pauls KA, Wieland K, et al. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain 2010;133:701-712.
12. Rana A, Seinen E, Siudeja K, et al. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci U S A 2010;107:6988-6993.
13. Zorzi G, Zibordi F, Chiapparini L, et al. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord 2011;26:1756-1759.